Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Incidence and Predictors of Early Treatment-Related Mortality In Pediatric Acute Lymphoblastic Leukemia In Baghdad (Iraq)

Anna Maria Testi, Robin Foa, Mazin Faisal Al-Jadiry, Maria Luisa Moleti, Salma Abbas Al-Hadad, Jawad Kadhum Al-Taee, Wisam Majeed Abed, Najiha Ahmed Ameen, Hasanein H. Ghali, Amir Fadhil Al-Darraji, Raghad Majid Al-Saeed, Valerio Cecinati, Annalisa De Vellis, Alfonso Piciocchi

Blood (2010) 116 (21): 2132.

https://doi.org/10.1182/blood.V116.21.2132.2132

Published: 2010

Journal Articles

Imatinib Mesylate Induces High Complete Cytogenetic and Molecular Response Rates in Children and Adolescents with Philadelphia Chromosome-Positive (Ph + ) Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP)

Fiorina Giona, Maria Caterina Putti, Maria Luisa Moleti, Mauro Nanni, Anna Maria Testi, Stefania Varotto, Enrico Marco Gottardi, Annalisa De Vellis, Vittorio Nunes, Daniela Diverio, Anna Leszl, Giuseppe Saglio, MD, Robert Foà

Blood (2008) 112 (11): 4273.

https://doi.org/10.1182/blood.V112.11.4273.4273

Published: 2008

Journal Articles

Bone Metabolism and Endocrine Function in Children with Chronic Myeloid Leukemia (CML) Treated with Imatinib during Puberty.

Fiorina Giona, MD, Stefania Mariani, MD, Annalisa De Vellis, MD, Maria Luisa Moleti, MD, Anna Maria Testi, MD, Mariella D’Angiò, MD, Bruna De Masi, MD, Robert Foa, MD, Lucio Gnessi, MD

Blood (2007) 110 (11): 2942.

https://doi.org/10.1182/blood.V110.11.2942.2942

Published: 2007

Journal Articles

Rituximab in Refractory Idiopathic Thrombocytopenic Purpura (ITP).

Cristina Santoro, MD, Francesca Biondo, MD, Gioia De Angelis, MD, Mariastefania De Propris, BD, Annalisa De Vellis, MD, Anna Guarini, BD, Luigi Malandruccolo, MD, Angela Rago, MD, Robert Foa, MD, Mariagabriella Mazzucconi, MD

Blood (2006) 108 (11): 3979.

https://doi.org/10.1182/blood.V108.11.3979.3979

Published: 2006

Journal Articles

Prevalence of Anti-HLA and Anti-GPIIB/IIIA Allo-Immunization in Patients with Glanzmann Thromboasthenia: Experience of a Single Center.

Cristina Santoro, MD, Angela Rago, MD, Angela Antenucci, BD, Antonio Chistolini, MD, Laura Conti, MD, Annalisa De Vellis, MD, Lucia Di Renzo, BD, Luca Laurenti, BD, Mariapaola Perrone, MD, Robert Foa, MD, Mariagabriella Mazzucconi, MD

Blood (2006) 108 (11): 3980.

https://doi.org/10.1182/blood.V108.11.3980.3980

Published: 2006

Journal Articles

Association of Hydroxyurea to Imatinib Is Effective in Patients with Chronic Myelogenous Leukemia Resistant to Imatinib Alone.

Roberto Latagliata, MD, Massimo Breccia, MD, Ida Carmosino, MD, Chiara Sarlo, MD, Rosa De Cuia, MD, Marco Mancini, MD, Francesca Biondo, MD, Eleonora Russo, MD, Annalisa De Vellis, MD, Daniela Diverio, MD, Franco Mandelli, PhD, Giuliana Alimena, PhD

Blood (2004) 104 (11): 4693.

https://doi.org/10.1182/blood.V104.11.4693.4693

Published: 2004

NARROW

Incidence and Predictors of Early Treatment-Related Mortality In Pediatric Acute Lymphoblastic Leukemia In Baghdad (Iraq)

Imatinib Mesylate Induces High Complete Cytogenetic and Molecular Response Rates in Children and Adolescents with Philadelphia Chromosome-Positive (Ph + ) Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP)

Bone Metabolism and Endocrine Function in Children with Chronic Myeloid Leukemia (CML) Treated with Imatinib during Puberty.

Rituximab in Refractory Idiopathic Thrombocytopenic Purpura (ITP).

Prevalence of Anti-HLA and Anti-GPIIB/IIIA Allo-Immunization in Patients with Glanzmann Thromboasthenia: Experience of a Single Center.

Association of Hydroxyurea to Imatinib Is Effective in Patients with Chronic Myelogenous Leukemia Resistant to Imatinib Alone.

Email alerts

ASH Publications

American Society of Hematology

Incidence and Predictors of Early Treatment-Related Mortality In Pediatric Acute Lymphoblastic Leukemia In Baghdad (Iraq)

Imatinib Mesylate Induces High Complete Cytogenetic and Molecular Response Rates in Children and Adolescents with Philadelphia Chromosome-Positive (Ph + ) Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP)

Bone Metabolism and Endocrine Function in Children with Chronic Myeloid Leukemia (CML) Treated with Imatinib during Puberty.

Rituximab in Refractory Idiopathic Thrombocytopenic Purpura (ITP).

Prevalence of Anti-HLA and Anti-GPIIB/IIIA Allo-Immunization in Patients with Glanzmann Thromboasthenia: Experience of a Single Center.

Association of Hydroxyurea to Imatinib Is Effective in Patients with Chronic Myelogenous Leukemia Resistant to Imatinib Alone.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only